Cooperative Agreement AID526A1300003

Federal Project Grant Award Summary Drive Medical, Inc. received a $631,494 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 8, 2025, with completion targeted for August 31, 2027. The company is developing the Pollywog, a disposable soft robotic enteroscope designed to provide safe and effective access to the small bowel for diagnostic and...

The Delta Regional Authority, a civilian federal agency, awarded a $255,736.82 Project Grant (CFDA 90.201 - Delta Area Economic Development) to Ochsner LSU Health System Of North Louisiana on September 15, 2023. The funding will be used to build a helipad adjacent to the emergency room, allowing quicker access for critical care patients. This project is expected to be completed by September 15, 2025. The Delta Area Economic Development program provides grants to support infrastructure, workforce...

Federal Grant Award Summary The Defense Health Agency (DHA) awarded Centre Hospitalier Universitaire Vaudois (CHUV) a $1.184 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. This award supports the development of a clinical-grade spinal cord neuroprosthesis designed to alleviate locomotor deficits in individuals with Parkinson's disease. The research is being conducted at CHUV's facilities in...

The Delta Regional Authority, a civilian federal agency, awarded a $450,000.00 Project Grant under the Delta Area Economic Development program (CFDA 90.201) to Green River Area Development District Inc. (Gradd), a regional planning and development organization serving western Kentucky. The award, with a period of performance from October 1, 2023 to October 1, 2025, will fund Gradd's efforts to HIRE TO OPERATE H2O, which involves operating water infrastructure programs and delivering related...

This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $148,942 to the Westfaelische Wilhelms-Universitaet Muenster in Germany to conduct research on identifying and characterizing the guanine nucleotide exchange factor (GEF) for the small GTPase Rheb as a novel target for treating tuberous sclerosis complex (TSC). The two-year award, running from July 1, 2024 to June 30, 2026, will support the university's...

Federal Project Grant Award Summary The Defense Health Agency awarded the University of Arkansas at Little Rock a $4.817 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2025, for a 36-month performance period concluding August 14, 2028. The project focuses on developing a novel biomedical platform for spine bone tissue regeneration, with the ultimate objective of advancing an innovative bone void filler toward FDA clearance for spinal...

Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Translational Genomics Research Institute (TGen) a $384,000 project grant effective September 1, 2025, through August 31, 2027, under the Military Medical Research and Development program (CFDA 12.420). The project, titled "Single: Signature Enabling Glioma Enrollment," supports research and development activities focused on glioma-related medical challenges. Based on TGen's established expertise in precision...

Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) awarded $513,535 to The University of Texas Southwestern Medical Center beginning June 1, 2026, through May 31, 2030. This Project Grant supports structure-guided discovery of positive allosteric modulators (PAMs) for the D2 dopamine receptor (DRD2), a G protein-coupled receptor central...

The Delta Regional Authority (DRA) awarded a $450,000 Project Grant under the Delta Area Economic Development (CFDA 90.201) program to the Nola Business Alliance (NOLABA), a non-profit economic development organization, to expand access to equitable opportunities in green infrastructure in New Orleans. The grant funding will support NOLABA's efforts to promote economic growth and resilience in the New Orleans region, including developing crucial biotech facilities and lab space, delivering...

Federal Project Grant Summary The Regenerative Research Foundation received a $233,550 Project Grant award dated June 1, 2026, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports a two-year research initiative (completion by May 31, 2028) to model myotonic dystrophy types 1 and 2 (DM1 and DM2) neuropathology using human induced pluripotent stem...